Using a blood test to predict Alzheimer s disease risk during symptom-free stage
Using a blood test, a German-Dutch research team has predicted the risk of Alzheimer s disease in people who were clinically diagnosed as not having Alzheimer s disease but who perceived themselves as cognitively impaired (Subjective Cognitive Declined, SCD). The researchers analyzed blood samples from an SCD cohort supervised at the Alzheimer Center Amsterdam.
Using a test developed at Ruhr-Universität Bochum (RUB) called the Immuno-Infrared Sensor, they identified all 22 subjects at study entry who developed Alzheimer s dementia, thus the clinical symptoms, within six years. The test also showed which subjects were at very low risk to develop Alzheimer s dementia within six years. The team describes the results in the journal
Credit: Michael Schwettmann
Using a blood test, a German-Dutch research team has predicted the risk of Alzheimer s disease in people who were clinically diagnosed as not having Alzheimer s disease but who perceived themselves as cognitively impaired (Subjective Cognitive Declined, SCD). The researchers analyzed blood samples from an SCD cohort supervised at the Alzheimer Center Amsterdam. Using a test developed at Ruhr-Universität Bochum (RUB) called the Immuno-Infrared Sensor, they identified all 22 subjects at study entry who developed Alzheimer s dementia, thus the clinical symptoms, within six years. The test also showed which subjects were at very low risk to develop Alzheimer s dementia within six years. The team describes the results in the journal